| Items | Drug Registration information |
|---|---|
| ID | 1620 |
| No | 1620 |
| Brand Name | ALIUPATINIB |
| Ingredients | UPADACITINIB 15 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | 28 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS, ACTIVE PSORIATIC ARTHRTIS, MODERATE TO SEVERE ULCERATIVE COLITIS, MODERATE TO SEVERE CHROHN'S DISEASE, ACTIVE ANKYLOSING SPONDYLITIS |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | PURPLE TABLET |
| Note | |
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 11 L 1260/24 |
| FDD Registration Date | 25/12/2024 |
| Expiry Date | 24/12/2029 |